Tagged: Pembrolizumab

June 11, 2019

Immunotherapy could help patients with recurrent head and neck cancer live longer

Immunotherapy used only or with chemotherapy shows improved survival in patients with relapsing head and neck cancer than standard aggressive chemotherapy, a new clinical trial result presented at the 2019 American Society of Clinical...

Pembrolizumab plus pemetrexed and carboplatin can improve 24-month overall survival for advanced nonsquamous non–small cell lung cancer

Know More About Cancer

February 20, 2019

Pembrolizumab plus pemetrexed and carboplatin can improve overall survival for advanced nonsquamous non–small cell lung cancer

Lung cancer is the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) is a more life-threatening type among lung cancer, accounting for about 80% to 85% of lung cancers. A pemetrexed...